Eunice Chang
Biographic Data
| ID | 5448455 |
|---|---|
| NAME | Eunice Chang |
| GIVEN NAMES | Eunice |
| FAMILY NAME | Chang |
| SIGNATURE | CHANG E |
| AFFILIATIONS | Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA |
| ORCID | 0000-0003-0177-6153 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 20 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2003 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 2 |
Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter–Related Complications
The burden of complications associated with peripheral intravenous use is underevaluated, in part, due to the broad use, inconsistent coding, and lack of mandatory reporting of these devices. This study aimed to analyze the clinical and economic impact of peripheral intravenous-related complications on hospitalized patients. This analysis of Premier Perspective ® Database US hospital discharge records included admissions occurring between July 1,…
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users
Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor indicated for treatment of HIV-1 infection. Despite concern over EFV tolerability in clinical trials and practice, particularly related to central nervous system (CNS) adverse events, some observational studies have shown high rates of EFV continuation at one year and low rates of CNS-related EFV substitution. The objective of this study was to further examine the real-world rate…
Ironic effects of explicit gender prejudice on women’s test performance
Medical and Mental Health Services Utilization among Requalified and Former Drug Addiction and Alcoholism Recipients of SSI
This article examines the impact of the elimination of the Supplemental Security Income (SSI) drug addiction and alcoholism (DA&A) disability category–-and the consequent loss of Medicaid benefits by most of those terminated from SSI–-on the medical and mental health services utilization of affected individuals. Data are from a two-year, five-wave panel study of a random sample of 1,764 former DA&A recipients in nine sites. Respondents were group…
Drug use Prevalence among Former SSI DA&A Recipients
This paper examines illegal drug use prevalence among former recipients of Supplemental Security Income (SSI) disability benefits for drug addiction and alcoholism (DA&A) in Chicago, Los Angeles, and Seattle, based on urinalysis and self-report data. It presents estimates of current prevalence (past three days) for four categories of illegal drugs–-opiates, cocaine, marijuana, or any use–-at 12 and 24 months after termination of the DA&A program.…
Ironic effects of explicit gender prejudice on women’s test performance
Drug use Prevalence among Former SSI DA&A Recipients
This paper examines illegal drug use prevalence among former recipients of Supplemental Security Income (SSI) disability benefits for drug addiction and alcoholism (DA&A) in Chicago, Los Angeles, and Seattle, based on urinalysis and self-report data. It presents estimates of current prevalence (past three days) for four categories of illegal drugs–-opiates, cocaine, marijuana, or any use–-at 12 and 24 months after termination of the DA&A program.…
Medical and Mental Health Services Utilization among Requalified and Former Drug Addiction and Alcoholism Recipients of SSI
This article examines the impact of the elimination of the Supplemental Security Income (SSI) drug addiction and alcoholism (DA&A) disability category–-and the consequent loss of Medicaid benefits by most of those terminated from SSI–-on the medical and mental health services utilization of affected individuals. Data are from a two-year, five-wave panel study of a random sample of 1,764 former DA&A recipients in nine sites. Respondents were group…
Medical and Mental Health Services Utilization among Requalified and Former Drug Addiction and Alcoholism Recipients of SSI
This article examines the impact of the elimination of the Supplemental Security Income (SSI) drug addiction and alcoholism (DA&A) disability category–-and the consequent loss of Medicaid benefits by most of those terminated from SSI–-on the medical and mental health services utilization of affected individuals. Data are from a two-year, five-wave panel study of a random sample of 1,764 former DA&A recipients in nine sites. Respondents were group…
Drug use Prevalence among Former SSI DA&A Recipients
This paper examines illegal drug use prevalence among former recipients of Supplemental Security Income (SSI) disability benefits for drug addiction and alcoholism (DA&A) in Chicago, Los Angeles, and Seattle, based on urinalysis and self-report data. It presents estimates of current prevalence (past three days) for four categories of illegal drugs–-opiates, cocaine, marijuana, or any use–-at 12 and 24 months after termination of the DA&A program.…
Ironic effects of explicit gender prejudice on women’s test performance
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users
Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor indicated for treatment of HIV-1 infection. Despite concern over EFV tolerability in clinical trials and practice, particularly related to central nervous system (CNS) adverse events, some observational studies have shown high rates of EFV continuation at one year and low rates of CNS-related EFV substitution. The objective of this study was to further examine the real-world rate…
Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter–Related Complications
The burden of complications associated with peripheral intravenous use is underevaluated, in part, due to the broad use, inconsistent coding, and lack of mandatory reporting of these devices. This study aimed to analyze the clinical and economic impact of peripheral intravenous-related complications on hospitalized patients. This analysis of Premier Perspective ® Database US hospital discharge records included admissions occurring between July 1,…
Medicine (4 works) · Internal Medicine (3 works) · Addiction (2 works) · Environmental health (2 works) · Family medicine (2 works) · Homelessness and Social Issues (2 works) · Internal Medicine (2 works) · Psychiatry (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Adverse effect (1 work)